Amorepacific Crecimiento futuro
Future controles de criterios 1/6
Se prevé que los beneficios de Amorepacific disminuyan en un 24% al año, mientras que se espera que sus ingresos anuales crezcan en un 10.2% al año. Se prevé que el BPA disminuya en un 21.9% por año. Se espera que la rentabilidad financiera sea de 7.1% en 3 años.
Información clave
-24.0%
Tasa de crecimiento de los beneficios
-21.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Personal Products | 10.1% |
Tasa de crecimiento de los ingresos | 10.2% |
Rentabilidad financiera futura | 7.1% |
Cobertura de analistas | Good |
Última actualización | 13 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Amorepacific's (KRX:090430) Returns On Capital Not Reflecting Well On The Business
Oct 06With EPS Growth And More, Amorepacific (KRX:090430) Makes An Interesting Case
Sep 24Estimating The Fair Value Of Amorepacific Corporation (KRX:090430)
Sep 12Should You Investigate Amorepacific Corporation (KRX:090430) At ₩124,400?
Aug 31Amorepacific Corporation's (KRX:090430) Share Price Is Still Matching Investor Opinion Despite 26% Slump
Aug 17Amorepacific (KRX:090430) Seems To Use Debt Rather Sparingly
Aug 11Is Amorepacific Corporation (KRX:090430) Potentially Undervalued?
May 23A Look At The Intrinsic Value Of Amorepacific Corporation (KRX:090430)
May 11Be Wary Of Amorepacific (KRX:090430) And Its Returns On Capital
Apr 29Amorepacific Corporation (KRX:090430) Looks Just Right With A 26% Price Jump
Apr 17Amorepacific (KRX:090430) Has A Pretty Healthy Balance Sheet
Apr 10Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues
Mar 14Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly
Mar 22Did You Miss Amorepacific's (KRX:090430) 41% Share Price Gain?
Mar 01Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 14Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate
Jan 31The Trends At Amorepacific (KRX:090430) That You Should Know About
Jan 18Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Jan 05Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?
Dec 21Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly
Dec 06Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?
Nov 20Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 4,788,486 | 433,797 | 490,792 | 587,037 | 25 |
12/31/2025 | 4,422,566 | 377,656 | 415,124 | 512,296 | 28 |
12/31/2024 | 3,860,580 | 684,417 | 469,708 | 613,904 | 23 |
9/30/2024 | 3,719,461 | 662,849 | 164,945 | 290,852 | N/A |
6/30/2024 | 3,631,085 | 653,214 | 206,972 | 337,367 | N/A |
3/31/2024 | 3,671,719 | 143,850 | 240,058 | 391,213 | N/A |
12/31/2023 | 3,673,964 | 152,522 | 174,760 | 348,228 | N/A |
9/30/2023 | 3,835,683 | 161,010 | 220,194 | 384,674 | N/A |
6/30/2023 | 3,883,262 | 157,219 | 283,188 | 453,528 | N/A |
3/31/2023 | 3,883,600 | 104,331 | 144,221 | 295,120 | N/A |
12/31/2022 | 4,134,933 | 134,475 | 16,101 | 151,024 | N/A |
9/30/2022 | 4,371,912 | 68,371 | 188,035 | 308,918 | N/A |
6/30/2022 | 4,544,441 | 84,039 | 240,729 | 357,734 | N/A |
3/31/2022 | 4,775,375 | 175,913 | 439,916 | 561,718 | N/A |
12/31/2021 | 4,863,128 | 193,681 | 570,824 | 691,434 | N/A |
9/30/2021 | 4,695,327 | 178,982 | 466,452 | 600,030 | N/A |
6/30/2021 | 4,675,027 | 148,728 | 498,866 | 651,475 | N/A |
3/31/2021 | 4,554,106 | 98,653 | 396,239 | 568,723 | N/A |
12/31/2020 | 4,432,179 | 35,132 | 339,700 | 554,359 | N/A |
9/30/2020 | 4,608,908 | 42,912 | 305,944 | 549,921 | N/A |
6/30/2020 | 4,922,270 | 137,275 | 363,995 | 625,898 | N/A |
3/31/2020 | 5,259,669 | 186,991 | 348,156 | 624,370 | N/A |
12/31/2019 | 5,580,142 | 238,804 | 439,375 | 718,301 | N/A |
9/30/2019 | 5,470,617 | 289,696 | 354,956 | 637,397 | N/A |
6/30/2019 | 5,347,037 | 234,594 | 124,318 | 483,115 | N/A |
3/31/2019 | 5,297,581 | 282,385 | 144,227 | 574,725 | N/A |
12/31/2018 | 5,277,845 | 332,195 | 191,031 | 646,677 | N/A |
9/30/2018 | 5,193,657 | 347,563 | -27,746 | 604,822 | N/A |
6/30/2018 | 5,125,097 | 377,054 | N/A | 618,357 | N/A |
3/31/2018 | 4,986,371 | 347,115 | N/A | 444,561 | N/A |
12/31/2017 | 5,123,826 | 394,011 | N/A | 512,563 | N/A |
9/30/2017 | 5,299,895 | 450,531 | N/A | 537,348 | N/A |
6/30/2017 | 5,490,953 | 488,541 | N/A | 615,218 | N/A |
3/31/2017 | 5,729,430 | 600,383 | N/A | 678,329 | N/A |
12/31/2016 | 5,645,440 | 639,255 | N/A | 676,952 | N/A |
9/30/2016 | 5,555,181 | 636,268 | N/A | 696,200 | N/A |
6/30/2016 | 5,295,359 | 658,995 | N/A | 628,452 | N/A |
3/31/2016 | 5,047,329 | 628,616 | N/A | 690,384 | N/A |
12/31/2015 | 4,766,627 | 577,523 | N/A | 627,504 | N/A |
9/30/2015 | 4,519,611 | 550,538 | N/A | 636,223 | N/A |
6/30/2015 | 4,375,235 | 515,495 | N/A | 686,149 | N/A |
3/31/2015 | 4,146,542 | 466,286 | N/A | 682,951 | N/A |
12/31/2014 | 3,874,008 | 379,104 | N/A | 586,111 | N/A |
9/30/2014 | 3,600,095 | 373,665 | N/A | 558,426 | N/A |
6/30/2014 | 3,396,154 | 335,996 | N/A | 475,093 | N/A |
3/31/2014 | 3,228,442 | 298,132 | N/A | 445,513 | N/A |
12/31/2013 | 3,100,413 | 267,975 | N/A | 426,657 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de A090430 disminuyan en los próximos 3 años (-24% al año).
Beneficios vs. Mercado: Se prevé que los beneficios de A090430 disminuyan en los próximos 3 años (-24% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de A090430 disminuyan en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (10.2% al año) de A090430 crezcan más rápidamente que los del mercado KR (9.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 10.2% al año) de A090430 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de A090430 sea baja dentro de 3 años (7.1%).